What community pharmacists should do. Pharmacies do not need to wait for the next wave of peptide expansion to begin building relevance in this space. One of the strongest opportunities today is positioning the pharmacy as a holistic care destination. Community pharmacists can strengthen relationships by starting these overall well-being conversations now, even when peptide therapy is not the immediate focus. Talk to patients about: * Available treatment options today * FDA-approved therapies versus investigational or off-label compounds * Medication risks, benefits, and realistic expectations * Lifestyle, nutrition, and supportive care considerations * Product quality, sourcing, and online purchasing concerns * Supplements & holistic products that can support their health goals Education matters. Many patients encounter peptide information through social media, influencer marketing, or fragmented online sources. Pharmacies can differentiate themselves by providing balanced, evidence-informed guidance rooted in clinical care. The pharmacies that build credibility now may be better prepared to meet future patient demand, evolving therapeutic trends, and changing healthcare expectations. Looking ahead. The peptide landscape is expanding rapidly. While not every peptide compound is FDA-approved or supported by robust evidence, patient interest is undeniable and growing. For community pharmacists, the opportunity is not simply to follow the trend. It is to understand the science, monitor the regulatory environment, educate patients responsibly, and position the pharmacy as a trusted partner in a changing therapeutic landscape. Michelle Barney, pharmd. Clinical Solutions Manager, Lumistry Michelle Barney is a Clinical Solutions Manager at Lumistry, where she brings the practicing pharmacist's perspective into the creation and evolution of pharmacy technology solutions. A clinical pharmacist by training, Michelle has built her career across retail pharmacy and health technology, including serving as Vice President of Clinical Operations at VUCA Health prior to its acquisition by Lumistry. She has held leadership roles spanning clinical operations, product, and marketing, and brings firsthand experience managing pharmacy teams and workflows. In her current role, Michelle partners closely with cross-functional teams to ensure Lumistry's products are rooted in real-world pharmacy needs - helping pharmacies work more efficiently, confidently, and effectively in their day-to-day practice. Browse by topic.

Lumistry has launched Voice AI Assistant, an AI-powered intelligent voice agent designed to modernise pharmacy phone systems. The solution replaces traditional keypad-based IVR systems with conversational AI that handles routine tasks through natural language interactions. Voice AI Assistant enables patients to request prescription refills, check prescription status, access pharmacy hours and location information, and transfer to staff when needed. The system supports multiple languages and integrates with pharmacy management systems. The product is part of Lumistry Voice, which now serves over 9,000 pharmacies nationwide. Lumistry CEO Tim Gill said the company plans to continue developing tools across the patient journey. The solution aims to reduce phone interruptions for pharmacy staff whilst maintaining personalised patient care.